Automated NGS Library Preparation Market Size, Share & Industry Analysis, By Product (Instruments, Kits & Reagents), By Type, By Workflow (Nucleic Acid Extraction, Fragmentation, Adapter Ligation), By Application, By End Use, By Region, and Regional Forecast, 2026-2034

The automated NGS library preparation market size was valued at USD 791.88 billion in 2025. The market is projected to grow from USD 898.11 billion in 2026 to USD 2458.43 billion by 2034, exhibiting a CAGR of 13.41% during the forecast period.

The automated NGS library preparation market covers instruments, kits, reagents, liquid-handling systems, and integrated laboratory platforms used to automate preparation of sequencing libraries before next-generation sequencing. Automation standardizes nucleic acid extraction, fragmentation, adapter ligation, purification, normalization, and related steps while reducing manual handling. Demand is supported by high-throughput genomic research, clinical diagnostics, oncology, drug discovery, reproductive testing, infectious disease analysis, and precision medicine. Kits and reagents remain the largest product category, while automated instruments are gaining importance as laboratories seek greater throughput and reproducibility. The automated NGS library preparation market is increasingly focused on flexible workflows, walk-away operation, sample tracking, and integration with sequencing systems.

The USA automated NGS library preparation market is a leading market because of extensive genomic research, pharmaceutical development, clinical sequencing, and adoption of laboratory automation. Universities, biotechnology companies, sequencing service providers, hospitals, and diagnostic laboratories increasingly use automated systems to process large sample volumes consistently. The United States also has strong demand for oncology sequencing, biomarker discovery, infectious disease testing, reproductive health diagnostics, and personalized medicine.

Automated platforms are particularly valuable where laboratories need reproducible sample processing and reduced hands-on time. The U.S. also benefits from the presence of major suppliers including Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad, Revvity, and Hamilton. The United States represented the largest individual country market in recent industry assessments.

Automated NGS Library Preparation Market Key Takeaways

Global Market Size & Forecast

• 2025 Market Size: USD 791.88 Billion
• 2026 Market Size: USD 898.11 Billion
• 2034 Forecast Market Size: USD 2458.43 Billion
• CAGR: 13.41% from 2026-2034

Market Share

• North America dominated the automated NGS library preparation market with a 39% share in 2025.
• Automated NGS library preparation instruments accounted for an estimated 35% share of the automated NGS library preparation market.
• Nucleic acid extraction accounted for an estimated 34% share of the workflow segment.

Key Regional Highlights

North America

North America dominated the automated NGS library preparation market with a 39% share in 2025.

Asia Pacific

Asia Pacific accounted for 24% of the automated NGS library preparation market share in 2025.

Europe

Europe held a 27% share of the automated NGS library preparation market in 2025.

U.S.

The U.S. market is supported by growing adoption of automated NGS technologies.

Japan

Japan accounted for 27% of the Asia Pacific automated NGS library preparation market in 2025.

Read More

Automated NGS Library Preparation Market Latest Trends

One of the strongest automated NGS library preparation market trends is the movement toward fully automated workflows rather than automation of isolated preparation steps. Laboratories increasingly want systems capable of managing extraction, fragmentation, adapter ligation, cleanup, normalization, indexing, and sample tracking through connected workflows. Platforms supporting up to 96 or more samples in a run are particularly relevant for high-throughput laboratories. Hamilton, for example, describes automated workflows capable of processing 96 samples with standardized protocols, barcode verification, temperature control, and automated error handling.

Another important trend is the integration of automation with targeted sequencing, whole-genome sequencing, whole-exome sequencing, RNA sequencing, oncology testing, and multiomic workflows. Automation providers are developing protocols compatible with different sequencing applications instead of relying on one universal workflow.

Reagent standardization is also becoming more important. Automated instruments are increasingly designed around ready-to-use kits and validated protocols, reducing optimization requirements for laboratory personnel. Illumina's automation ecosystem, for example, supports automated protocols through multiple liquid-handling partners and offers workflows for oncology and other sequencing applications.

The automated NGS library preparation market is also seeing increased emphasis on compact automation, software-controlled workflow management, barcode tracking, liquid-level monitoring, error detection, and flexible throughput. These features allow laboratories to select automation according to sample volume rather than purchasing oversized systems.

Download Free sample to learn more about this report.

Automated NGS Library Preparation Market Dynamics

DRIVER

Rising demand for high-throughput genomic sequencing and reproducible sample preparation

The primary driver of the automated NGS library preparation market is the increasing volume and complexity of next-generation sequencing workloads. NGS laboratories frequently process dozens or hundreds of samples simultaneously, making manual preparation difficult to scale. Manual pipetting, repeated transfers, reagent handling, and cleanup can increase variability and consume substantial laboratory time.

Automated library preparation addresses these limitations by standardizing liquid handling and controlling critical processing conditions. Automation can improve consistency between batches, reduce hands-on time, increase walk-away operation, and support higher sample throughput. These advantages are especially valuable for pharmaceutical companies, biotechnology organizations, sequencing service providers, research institutes, and clinical laboratories.

The growing use of NGS in oncology, rare disease research, drug discovery, infectious disease testing, reproductive health, and precision medicine further increases the need for reliable sample preparation. As sequencing projects become larger, laboratories require scalable workflows that can handle different sample types and library protocols.

The expanding adoption of targeted sequencing and whole-genome sequencing is also encouraging laboratories to automate preparation steps. Industry analysis identifies high-throughput sequencing demand, reproducibility requirements, genomic research, and personalized medicine as major factors supporting automated library preparation adoption.

RESTRAINT

High initial investment and workflow integration complexity

The major restraint in the automated NGS library preparation market is the initial cost and complexity associated with implementing automated systems. Laboratories must consider instruments, software, consumables, maintenance, validation, training, and workflow customization. Smaller laboratories may find it difficult to justify automation when sample volumes are low or irregular.

Integration can also be challenging. NGS library preparation protocols vary according to sample type, sequencing platform, assay chemistry, indexing strategy, and downstream application. Laboratories may need to validate automated workflows extensively before using them for regulated clinical applications.

Consumable compatibility represents another concern. Some automation systems work most efficiently with particular reagent formats, plates, tips, or sequencing kits. Switching protocols may require additional programming and validation.

The shortage of laboratory personnel with automation and genomics expertise can further slow adoption. Operators must understand both NGS chemistry and liquid-handling technology to troubleshoot problems effectively.

Despite these restraints, the increasing need for standardized and scalable workflows is encouraging laboratories to evaluate automation as a long-term productivity investment rather than simply an equipment purchase.

OPPORTUNITY

Expansion of integrated, flexible, and application-specific automation platforms

A major opportunity for the automated NGS library preparation market is the development of flexible platforms capable of supporting multiple sequencing applications. Laboratories increasingly want one automation system that can accommodate DNA sequencing, RNA sequencing, targeted panels, whole-genome sequencing, whole-exome sequencing, and enrichment workflows.

Another opportunity is compact automation for laboratories with moderate sample volumes. Entry-level systems can provide automation benefits without requiring large laboratory footprints. This can expand adoption among academic laboratories, smaller biotechnology companies, regional diagnostic centers, and specialized research facilities.

Cloud-connected workflow management and laboratory information system integration also offer opportunities. Automated instruments can record sample identities, reagent information, run parameters, and processing steps, improving traceability.

There is substantial potential for AI-assisted workflow monitoring, automated error detection, predictive maintenance, and adaptive liquid handling. Suppliers that combine robotics, software, consumables, and sequencing compatibility can create more complete laboratory solutions.

The growth of clinical sequencing provides another important opportunity. As sequencing moves into routine diagnostics, laboratories require reproducible and validated preparation processes. Automated NGS library preparation can support standardized testing environments while reducing repetitive manual work.

CHALLENGE

Maintaining flexibility, accuracy, and reproducibility across diverse NGS workflows

The biggest challenge is balancing automation with the highly variable nature of NGS workflows. Different sequencing applications require different fragmentation conditions, adapter concentrations, cleanup ratios, indexing approaches, and amplification strategies. An automation platform must therefore be flexible without compromising consistency.

Sample quality is another challenge. Poor-quality DNA or RNA can negatively affect downstream sequencing regardless of how accurately the library preparation instrument operates. Automated systems need mechanisms for detecting sample-related problems and handling variations in input concentration.

Cross-contamination prevention is also critical. High-throughput systems process many samples in parallel, so instrument design must minimize carryover and ensure appropriate tip management, plate handling, and workflow separation.

Clinical laboratories face additional validation and documentation requirements. Automation software, reagent lots, instrument performance, and workflow changes may need controlled validation.

Laboratories also need dependable technical support. If an automated platform stops functioning during a large sequencing project, delays can affect downstream sequencing schedules. Vendors therefore need strong service infrastructure, remote diagnostics, replacement strategies, and application support.

Automated NGS Library Preparation Market Segmentation

By Product

Automated NGS library preparation instruments account for an estimated 35% share of the automated NGS library preparation market. These systems include robotic liquid handlers, integrated assay-ready workstations, automated cleanup platforms, and specialized sequencing library preparation systems.

Instrument demand is being supported by laboratories seeking greater throughput and reduced hands-on intervention. Modern platforms can automate pipetting, reagent dispensing, magnetic-bead cleanup, incubation, temperature-controlled steps, mixing, indexing, and plate movement. Some systems also include barcode verification and software-controlled workflow management.

High-throughput instruments are particularly important for pharmaceutical and biotechnology companies conducting large sequencing studies. Clinical laboratories and sequencing service providers also benefit from automation because standardized workflows can support predictable turnaround times.

The instrument segment is evolving toward modular configurations. Laboratories can select compact systems for smaller workloads or high-throughput platforms for larger projects. Current commercial platforms include systems from Agilent, Hamilton, Revvity, Tecan, Beckman Coulter, and other automation suppliers.

Kits and reagents represent the largest product category, accounting for an estimated 65% share. The segment includes DNA library preparation kits, RNA library preparation kits, targeted enrichment materials, adapter reagents, indexing components, enzymes, magnetic beads, and other consumables required to construct sequencing-ready libraries.

The recurring nature of reagent consumption makes this segment strategically important. Every sequencing project requires compatible preparation materials, creating continuing demand after laboratories purchase automation instruments.

Automated workflows particularly benefit from standardized reagent formats because preconfigured kits reduce protocol variability. Suppliers increasingly design kits for specific automation platforms and sequencing applications.

Demand is also supported by the expansion of targeted sequencing, RNA sequencing, whole-genome sequencing, oncology panels, and biomarker discovery. Industry data indicates that kits and reagents represented the dominant product segment, reflecting their critical role in automated workflows.

To know how our report can help streamline your business, Speak to Analyst

By Workflow

Nucleic acid extraction accounts for an estimated 34% share of the workflow segment. High-quality DNA and RNA are essential inputs for successful library preparation, making extraction a critical stage for downstream sequencing accuracy.

Automation can standardize sample lysis, binding, washing, elution, and magnetic-bead separation. Automated extraction is particularly useful in laboratories processing large numbers of clinical or research samples.

Integration between extraction and library preparation is becoming increasingly attractive because it reduces manual transfers. Fully connected workflows can move samples from primary processing into library construction while preserving sample identity through barcode tracking.

Fragmentation represents approximately 24% of the workflow segment. The process converts DNA into fragments of appropriate size for sequencing library construction. Automated fragmentation can improve consistency by precisely controlling reaction conditions and processing times.

Enzymatic fragmentation is receiving increasing attention because it can simplify workflows and reduce dependence on mechanical equipment. Industry analysis identifies fragmentation as an important area for automation innovation due to increasing sequencing throughput and the need for precise fragment sizes.

Adapter ligation accounts for approximately 22% of the workflow segment. During this stage, sequencing adapters are attached to DNA fragments, enabling subsequent amplification, indexing, and sequencing.

Automation improves reagent dispensing accuracy and helps standardize incubation conditions. Accurate adapter handling is particularly important for multiplexed sequencing because incorrect concentrations or sample indexing can affect library quality and downstream data interpretation.

By Application

Drug and biomarker discovery accounts for an estimated 39% share of the application segment. Pharmaceutical and biotechnology companies use NGS to investigate genetic variation, identify disease mechanisms, characterize biomarkers, and support development of targeted therapies.

Automated library preparation is particularly valuable for large studies where hundreds or thousands of samples must be processed consistently. Standardization reduces variation between batches and supports more predictable sequencing workflows. NGS is increasingly used for genetic disorders, oncology, infectious diseases, and other diagnostic applications. Automation helps diagnostic laboratories manage increasing sample volumes while maintaining standardized preparation procedures. As sequencing becomes more integrated into routine testing, automated systems can support traceability and reproducibility.

Tumor sequencing, liquid biopsy, molecular profiling, and biomarker testing require precise preparation of often limited clinical samples. Automated library preparation is particularly useful when laboratories process large oncology panels. It can reduce manual variability and help standardize sample handling across multiple batches. NGS applications in reproductive health include genetic screening and analysis of inherited conditions.

Automation supports laboratories processing large sample volumes while maintaining consistent preparation protocols. The segment is also benefiting from increasing use of molecular testing in fertility and reproductive medicine.

By End Use

Pharmaceutical and biotechnology companies represent approximately 43% of the end-use segment. These organizations use automated library preparation for drug discovery, biomarker research, translational studies, clinical research, and precision medicine. Adoption is increasing as molecular diagnostics and oncology sequencing become more integrated into healthcare. Universities use automation to support genomic research while reducing repetitive laboratory work. organizations benefit from scalable workflows because they routinely process samples for multiple customers and research programs.

By Region

Regional demand is shaped by sequencing infrastructure, healthcare investment, pharmaceutical research, availability of laboratory automation expertise, and adoption of precision medicine. North America remains the leading region, while Asia-Pacific presents substantial expansion opportunities. Europe maintains strong demand through research institutes, pharmaceutical organizations, clinical laboratories, and public genomic programs.

Automated NGS Library Preparation Market Regional Outlook

North America

To get more information on the regional analysis of this market, Download Free sample

North America represents approximately 39% of the automated NGS library preparation market. The region benefits from advanced genomic research infrastructure, strong pharmaceutical and biotechnology industries, established sequencing laboratories, and widespread adoption of laboratory automation.

The United States is the major contributor, supported by extensive oncology research, drug discovery programs, clinical sequencing, and precision medicine. Automated library preparation is increasingly used by laboratories that need to process large numbers of samples with consistent workflows.

Canada also contributes through academic genomics, clinical research, and biotechnology development. The region has a mature ecosystem of sequencing instrument suppliers, reagent manufacturers, automation companies, and laboratory software providers.

Commercial platforms increasingly emphasize compatibility with established NGS workflows. Illumina describes automated protocols supporting multiple liquid-handling partners, while Hamilton provides dedicated NGS automation systems for different throughput requirements.

The combination of high sequencing volumes, advanced laboratory infrastructure, and strong investment in molecular diagnostics makes North America an important market for automated library preparation.

Europe

Europe accounts for approximately 27% of the automated NGS library preparation market. Germany, the United Kingdom, France, Switzerland, and other European countries have established biotechnology and pharmaceutical sectors supporting demand for sequencing automation.

European laboratories increasingly use NGS for oncology, inherited disease research, infectious disease analysis, biomarker discovery, and population genomics. Automation supports these activities by improving consistency and reducing repetitive manual processing.

The region also has strong demand for laboratory standardization and traceability. Automated platforms equipped with barcode tracking, workflow software, and controlled protocols can help laboratories maintain documented sample histories.

Pharmaceutical research is another important contributor. European drug developers increasingly use genomic information in biomarker programs and precision medicine, increasing demand for scalable sequencing workflows.

Germany

Germany represents approximately 29% of the European automated NGS library preparation market. The country has a strong pharmaceutical, biotechnology, diagnostic, and academic research ecosystem. Genomic testing is increasingly important in oncology, rare disease research, infectious disease investigation, and molecular diagnostics.

German laboratories are adopting automation to improve workflow standardization and reduce manual intervention. High-throughput research centers particularly benefit from automated extraction, library construction, cleanup, and sample tracking.

The country's engineering expertise also supports adoption of advanced laboratory robotics. Suppliers can target Germany with modular platforms that combine high precision, flexible programming, and integration with laboratory information systems.

Clinical applications represent an important long-term opportunity as molecular diagnostics become more widely incorporated into healthcare. Pharmaceutical and biotechnology research remains another significant source of demand.

United Kingdom

The United Kingdom accounts for approximately 23% of Europe's automated NGS library preparation market. The country has a strong genomics ecosystem supported by research institutions, biotechnology companies, pharmaceutical organizations, and diagnostic laboratories.

NGS is widely relevant to cancer research, inherited disease analysis, infectious disease monitoring, and population genomics. Automated library preparation allows laboratories to manage high sample volumes while maintaining standardized procedures.

The UK also offers opportunities for automation companies supporting centralized sequencing facilities and large research programs. Cloud-based workflow management, sample tracking, and laboratory software integration can further improve operational efficiency.

Demand is expected to remain centered on scalable platforms, validated workflows, and systems capable of supporting different sequencing technologies. Vendors with strong technical support and flexible automation protocols can compete effectively in this market.

Asia-Pacific

Asia-Pacific represents approximately 24% of the automated NGS library preparation market. The region is experiencing increasing adoption of genomics, molecular diagnostics, precision medicine, and biotechnology research.

China and Japan are major contributors, while South Korea, Australia, Singapore, and India are also expanding genomic research capabilities. Laboratories in these countries increasingly require automation to manage growing sample volumes.

The region provides significant opportunities for cost-efficient and scalable automation. Smaller laboratories may prefer compact systems, while large sequencing centers require high-throughput platforms capable of processing hundreds of samples.

The development of local biotechnology industries is also encouraging demand for automated workflows. Increasing investment in cancer genomics, inherited disease testing, infectious disease research, and population genomics is expanding the addressable market.

Japan

Japan represents approximately 27% of the Asia-Pacific automated NGS library preparation market. The country has advanced healthcare infrastructure, strong life-science research capabilities, and a highly developed laboratory technology environment.

NGS applications include oncology, rare disease research, molecular diagnostics, and pharmaceutical development. Automated library preparation can help Japanese laboratories reduce repetitive manual work and improve consistency.

Compact, precise, and highly reliable systems are particularly attractive in environments where laboratory space and workflow efficiency are important. Vendors can also benefit from developing automation solutions that integrate with existing Japanese laboratory systems.

Research institutions and pharmaceutical companies remain important customers, while clinical sequencing provides another area of opportunity.

China

China accounts for approximately 36% of the Asia-Pacific automated NGS library preparation market. The country has rapidly expanded genomic research, biotechnology, molecular diagnostics, and sequencing infrastructure.

Large research organizations and sequencing service providers increasingly require automated workflows capable of processing high sample volumes. Automation is particularly relevant to oncology sequencing, population genomics, infectious disease research, and drug discovery.

Domestic biotechnology development is creating additional demand for laboratory automation. Suppliers can address this opportunity through scalable systems, localized technical support, compatible reagents, and software capable of integrating with laboratory information systems.

China is also becoming increasingly important for sequencing-based clinical research, making automated preparation a strategic component of larger genomic workflows.

Rest of World

Rest of World represents approximately 10% of the automated NGS library preparation market. This category includes Latin America, the Middle East, and Africa, where genomic infrastructure is developing at different rates.

Major opportunities exist in research institutions, hospitals, molecular diagnostic laboratories, pharmaceutical companies, and centralized sequencing centers. Automation can be particularly valuable where laboratories face shortages of trained technical staff.

However, equipment affordability, maintenance infrastructure, reagent availability, technical training, and regulatory requirements can influence adoption. Compact automation systems and reagent-efficient workflows may therefore be more attractive than highly complex platforms.

As precision medicine and molecular diagnostics expand, demand for standardized library preparation is expected to increase. Partnerships with local distributors, research institutions, and healthcare organizations can help international suppliers establish sustainable market presence.

List of Top Automated NGS Library Preparation Companies

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• QIAGEN N.V.
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories, Inc.
• Revvity, Inc.
• Oxford Nanopore Technologies Ltd.
• Pacific Biosciences of California, Inc.
• Hamilton Company

Top Two Companies by Market Share

• Illumina, Inc.: 27%
• Thermo Fisher Scientific Inc.: 21%

Investment Analysis and Opportunities

Investment opportunities in the automated NGS library preparation market are concentrated around high-throughput instruments, consumable kits, integrated laboratory automation, sequencing workflow software, and application-specific solutions. Pharmaceutical and biotechnology companies remain important buyers because genomic research increasingly requires processing large sample cohorts.

The recurring demand for kits and reagents provides an attractive commercial model, while instruments offer opportunities for technological differentiation through faster processing, improved precision, flexible deck configurations, barcode tracking, and software integration.

Investors are also evaluating automation solutions designed for clinical laboratories. As NGS expands into diagnostics, laboratories require standardized workflows that can support reproducibility and traceability.

Another opportunity is the development of automation systems for emerging sequencing applications such as multiomics, single-cell analysis, liquid biopsy, spatial genomics, and increasingly complex targeted panels. Companies that can integrate library preparation with extraction and downstream sequencing preparation may achieve stronger positioning.

The automated NGS library preparation market outlook also supports investment in compact automation, especially for smaller laboratories that need scalable technology without the complexity of large robotic systems.

New Product Development

New product development is increasingly focused on flexible automation, smaller footprints, higher sample throughput, integrated software, and compatibility with diverse NGS protocols. Manufacturers are developing systems that can automate multiple preparation stages rather than relying on separate instruments.

Hamilton's NGS STAR family, for example, includes systems designed for different throughput requirements, including compact workflows and high-throughput preparation. Its NGS STAR V platform supports automated library preparation and standardized workflows.

Illumina is also expanding automated library preparation compatibility through collaborations with multiple automation providers. Its automation resources include workflows for oncology assays and other sequencing applications, demonstrating the industry's shift toward validated instrument-kit combinations.

Future products are likely to include stronger barcode verification, automated liquid-level sensing, integrated normalization, real-time workflow monitoring, AI-assisted error detection, and broader laboratory information system connectivity.

Reagent development is equally important. Kits optimized for automation can reduce manual optimization and provide consistent reaction conditions. The combination of specialized consumables and flexible robotic platforms is expected to remain central to automated NGS library preparation market opportunities.

Five Recent Developments (2023-2025)

• 2023 – Expansion of automated oncology workflows: Automated preparation protocols for advanced oncology sequencing assays were expanded across liquid-handling platforms, supporting higher-throughput processing and reduced hands-on time.
• 2024 – Increased adoption of high-throughput NGS automation: Automation suppliers expanded workflows for DNA and RNA library preparation, including systems capable of processing up to 96 samples in a single automated run.
• 2024 – Growth of integrated library preparation platforms: Suppliers increasingly combined liquid handling, temperature control, magnetic-bead processing, barcode verification, and software-controlled workflow management.
• 2025 – Expansion of automation-ready protocols: Illumina's automation ecosystem continued supporting protocols across Hamilton, Beckman Coulter, Eppendorf, Revvity, Tecan, and SPT Labtech platforms, strengthening interoperability across laboratory automation environments.
• 2025 – Greater emphasis on clinical and high-throughput automation: Commercial automation platforms increasingly targeted clinical NGS, oncology, RNA sequencing, whole-genome sequencing, and target-enrichment workflows, reflecting the industry's movement toward standardized end-to-end sequencing preparation.

Report Coverage of Automated NGS Library Preparation Market

The automated NGS library preparation market report covers instruments, kits and reagents, workflow automation, sequencing applications, end-use industries, regional markets, competitive positioning, investments, product development, and recent manufacturer developments. The automated NGS library preparation market analysis focuses on how automation is transforming nucleic acid extraction, fragmentation, adapter ligation, purification, quantification, indexing, and other preparation activities.

The automated NGS library preparation market research report evaluates demand across pharmaceutical and biotechnology companies, hospitals, clinics, academic institutions, sequencing service providers, and research organizations. It also assesses the role of automation in drug and biomarker discovery, disease diagnostics, cancer diagnostics, reproductive health, infectious disease testing, and genomic research.

The automated NGS library preparation industry report provides B2B-focused insights into purchasing priorities, workflow scalability, instrument utilization, consumable demand, automation compatibility, laboratory productivity, and technology development. The automated NGS library preparation industry analysis also considers competitive opportunities created by increasing NGS throughput.

The automated NGS library preparation market forecast outlook is influenced by sequencing adoption, precision medicine, genomic research, clinical diagnostics, automation investment, and demand for standardized sample preparation. The automated NGS library preparation market Insights highlight opportunities for manufacturers, distributors, laboratory automation companies, biotechnology organizations, pharmaceutical companies, and diagnostic providers.